en · de · es · fr · pt
aod-9604-notes.peptides3081.com › Topic › Mechanism And Regulatory Status — Quick Reference

Mechanism And Regulatory Status — Quick Reference

By Editorial Desk · published 2026-02-07 · last reviewed 2026-03-18 · Topic

lipolysis is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Last reviewed on 2026-03-18. Where a claim depends on a specific study, the study is described rather than over-claimed.

Mechanism and Regulatory Status

Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.

Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.

Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.

Measurement and Storage Practices

Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.

Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.

Aod-9604 at a glance

PropertyValueNotes
Typical storage temperature-20 °CLyophilized peptide; protect from moisture and light.
Typical analytical methodHPLC and mass spectrometryUsed to confirm identity and estimate purity.
Common synonymsAOD9604; hGH 176-191Naming varies by supplier and publication.
Disulfide bondsOneAffects folded structure and stability.
Typical research purity≥95%Value depends on supplier and analytical method.

Research and Regulatory Status

Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.

AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.

Related pages on this site

Regulation and Detection Context

Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.

Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.

Supporting material

=== Brain surgeries === In February 1988, after several episodes of severe neck pain, Biden underwent surgery to correct a leaking intracranial berry aneurysm. While recuperating, he suffered a pulmonary embolism. A second aneurysm was surgically repaired in May. His recuperation kept him away from the Senate for seven months.

== Background == Scientists have debated whether umami was a basic taste since Kikunae Ikeda first proposed its existence in 1908. In 1985, the term umami was recognized as the scientific term to describe the taste of glutamates and nucleotides at the first Umami International Symposium in Hawaii. Umami represents the taste of the amino acid L-glutamate and 5'-ribonucleotides such as "inosinate and guanylate". (guanosine monophosphate, GMP, and inosine monophosphate, IMP). It can be described as a pleasant "brothy" or "meaty" taste with a long-lasting, mouthwatering, and coating sensation over the tongue. Umami enhances the palatability of a wide variety of foods. Studies in genetically engineered mice in which individual TAS1R genes have been deleted indicate that the TAS1R1/TAS1R3 complex is solely responsible for umami taste, whereas TAS1R2/TAS1R3 is solely responsible for sweet taste. As expected, a genetic knockout of TAS1R1 selectively abolishes umami taste, a knockout of TAS1R2 specifically abolishes sweet taste, while a knockout of TAS1R3 eliminates both sweet and umami taste. Specialized taste bud cells detect the chemical species perceived as umami by humans. Glutamate in acid form (glutamic acid) imparts little umami taste, whereas the salts of glutamic acid, known as glutamates, give the characteristic umami taste due to their ionized state. GMP and IMP amplify the taste intensity of glutamate. Adding salt to the free acids also enhances the umami taste.

The chorionic villi form the principal exchange surface between the maternal and fetal circulations. Maternal blood flows through the intervillous space and directly bathes the external surface of the villi, while fetal blood remains within capillaries in the villous cores. The two circulations therefore normally remain anatomically separate. The surface of each villus is formed by the syncytiotrophoblast, a continuous, terminally differentiated, multinucleated epithelium without lateral cell boundaries. Its maternal-facing surface bears numerous microvilli that increase the area available for exchange. Beneath it are individual mononuclear villous cytotrophoblasts, which serve as progenitor cells and fuse with the overlying syncytiotrophoblast. Cytotrophoblasts form a conspicuous, nearly continuous layer early in pregnancy but become sparse and discontinuous as gestation advances. The villous core consists of fetal connective tissue containing capillaries, fibroblasts and fetal macrophages known as Hofbauer cells. Near term, many fetal capillaries are positioned immediately beneath attenuated areas of syncytiotrophoblast. These thin regions, termed vasculosyncytial membranes, minimize the diffusion distance between maternal and fetal blood. The exchange barrier at these sites consists principally of syncytiotrophoblast, closely approximated basement membranes, and fetal capillary endothelium. Syncytial knots are localized aggregates of syncytiotrophoblastic nuclei protruding from the villous surface.

==== HKUST-1 ==== HKUST-1 consists of a dimeric Cu-paddlewheel that possesses two pore types. Under pelletization MOFs such as HKUST-1 exhibit a pore collapse. Although most carboxylate MOFs have a negative thermal expansion (they densify during heating), it was found that the hardness and Young's moduli unexpectedly decrease with increasing temperature from disordering of linkers. It was also found computationally that a more mesoporous structure has a lower bulk modulus. However, an increased bulk modulus was observed in systems with a few large mesopores versus many small mesopores even though both pore size distributions had the same total pore volume. The HKUST-1 shows a similar, "hyperfilling" phenomenon to the ZIF structures under hydrostatic loading.

Sources: en.wikipedia.org

Notes from published material

== Conservation == It is widespread and common in the United Kingdom and North America (August–October) except for the southeast United States. It is protected in parts of Poland and is of conservation concern in Norway.

Depending on their chemical structures, polymers may be either semi-crystalline or amorphous. Semi-crystalline polymers can undergo crystallization and melting transitions, whereas amorphous polymers do not. In polymers, crystallization and melting do not suggest solid-liquid phase transitions, as in the case of water or other molecular fluids. Instead, crystallization and melting refer to the phase transitions between two solid states (i.e., semi-crystalline and amorphous). Crystallization occurs above the glass-transition temperature (Tg) and below the melting temperature (Tm).

=== Crime === Belize has moderate rates of violent crime. The majority of violence in Belize stems from gang activity, which includes trafficking of drugs and persons, protecting drug smuggling routes, and securing territory for drug dealing. In 2023, 87 murders were recorded in Belize, giving the country a homicide rate of 19.7 murders per 100,000 inhabitants, lower than the neighbouring countries of Mexico and Honduras, but higher than Guatemala and El Salvador. Belize District (containing Belize City) had the most murders by far compared to all the other districts. In 2023, 66% of the murders occurred in the Belize District. The violence in Belize City (especially the southern part of the city) is largely due to gang warfare. In 2023, there were 34 reported cases of rape, 170 robberies, 628 burglaries, and 118 cases of theft.

=== 21st century === The West China University of Medical Sciences merged with Sichuan University in 2000. The dental school and hospital adopted their current Sichuan University names in 2001, becoming the West China School of Stomatology and the West China Hospital of Stomatology. A new clinical building was completed in 2009, followed by a dedicated research building in 2010. During the 2000s and 2010s, the institution also expanded its national research infrastructure, including laboratories in oral diseases, regenerative medicine and clinical research. In 2020, the National Health Commission entrusted the institution to serve as one of the three National Centers for Stomatology (国家口腔医学中心) in the country. The stomatology national-center system was designed to concentrate expertise in the diagnosis and treatment of complex oral diseases, professional training, clinical research, standards development, and quality control.

In August 2024, the SURMOUNT-1 three-year study (176-week treatment period) found that tirzepatide reduced the risk of developing type 2 diabetes by 94% in adults with pre-diabetes and obesity or overweight.

Sources: en.wikipedia.org

Background from the literature

== Clinical significance == Homozygous mutations, heterozygous compound (bi-allelic) mutations or haploinsufficiency in TN-X cause classical-like Ehlers–Danlos syndrome (EDS), a rare and hereditary connective tissue disorder in mice and humans. This pathology is characterized by skin hyperlaxity, joint hypermobility and global tissue weakness as a consequence of elastin fragmentation and reduced collagen density, especially in skin.

Nonbenzodiazepines also bind to the benzodiazepine binding site on the GABAA receptor and possess similar pharmacological properties. While the nonbenzodiazepines are by definition structurally unrelated to the benzodiazepines, both classes of drugs possess a common pharmacophore (see figure to the lower-right), which explains their binding to a common receptor site. Not all benzodiazepines increase the conductance of the GABAA receptor. Flumazenil, an imidazobenzodiazepine, is an antidote for some benzodiazepine overdoses. The structural scaffold can even be used to target receptors other than GABAA.

Cochrane concluded that the "Existing evidence on the safety and effectiveness of MMR and MMRV vaccine supports current policies of mass immunisation aimed at global measles eradication to reduce morbidity and mortality associated with measles mumps rubella and varicella." The combined MMR vaccine induces immunity less painfully than three separate injections at the same time, and sooner and more efficiently than three injections given on different dates. Public Health England reports that providing a single combined vaccine as of 1988, rather than giving the option to have them also done separately, increased uptake of the vaccine.

Voice of Reason (Greek: Φωνή Λογικής, romanized: Foní Logikís, FL) is a far-right ultranationalist political party in Greece. It was established in 2023 by Afroditi Latinopoulou, a lawyer and former tennis player.

Sources: en.wikipedia.org

Frequently asked questions

Is AOD-9604 approved for weight loss?

No. Major drug regulators have not approved AOD-9604 for weight loss or any other therapeutic indication. It remains an investigational compound studied in research settings.

Why is AOD-9604 banned in sports?

The World Anti-Doping Agency classifies it as a prohibited peptide hormone. Athletes under anti-doping rules are not permitted to use it. Its presence can trigger a doping violation.

Does AOD-9604 raise growth hormone levels?

It is a fragment of growth hormone rather than a substance that signals the pituitary to release more hormone. Studies have not shown a consistent rise in IGF-1 or full growth hormone. Its metabolic effects, if any, appear separate from those of the complete hormone.

How is AOD-9604 typically analyzed?

Reversed-phase HPLC is used to assess purity, and mass spectrometry confirms molecular mass. Amino acid analysis can verify composition. These methods are standard for peptide characterization.

Network